skip to main content

We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.

Eric Stone Speaks About Biosimilars in U.S. Patent Disputes at Fordham IP Institute

Litigation partner Eric Stone will participate in the 23rd Annual Fordham Intellectual Property Law & Policy Conference. Eric will be speaking on, "Biosimilars Come to the U.S.: An overview of how patent disputes are to be handled under the U.S. Biologics Price Competition and Innovation Act." The event will take place on April 8-9 in Cambridge, U.K.

© 2020 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy